# Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis

> **NCT05795491** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Recurrent Vulvovaginal Candidiasis

## Interventions

- **DEVICE:** Blue Light Emitting Diode Therapy
- **DRUG:** Azole Antifungal

## Key facts

- **NCT ID:** NCT05795491
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795491, "Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05795491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*